NASDAQ · Healthcare · Drug Manufacturers - General
Gilead Sciences, Inc.
GILD
Gilead Sciences, Inc. CEO Daniel O'Day · Market cap $187.4B.
$151.17
+4.07 · +2.77%
52w hi $157.2952w lo $114.02
44
ROUTINE
Current InsiderScore
Corp · 90d
0
0 buys · 0 sales
Cong · 90d
1
0 buys · 1 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
No filings yet
No Form 4 filings on record. As the backfill progresses this will populate.
Section 02
Recent STOCK Act disclosures
4 disclosures on file
| Disclosed | Legislator | Chamber · State | Action | Range | Midpoint | Delay | Score |
|---|---|---|---|---|---|---|---|
| Sep 07 | Ro Khanna | House · CA | Sell | $1,001 - $15,000 | $8K | 28 d | 44 |
| Aug 12 | Ro Khanna | House · CA | Sell | $1,001 - $15,000 | $8K | 36 d | 40 |
| Jun 22 | Jared Moskowitz | House · FL | Buy | $1,001 - $15,000 | $8K | 47 d | 36 |
| Feb 27 | Josh Gottheimer | House · NJ | Buy | $1,001 - $15,000 | $8K | 31 d | 37 |
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct